Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma.
Wei WangDongMei ZouZhe ZhuangXiao ZhangLi ZhangJingJing YinCongWei JiaLi YuanHao CaiYan ZhangXuan WangMei-Fen ZhangDao-Bin ZhouWei ZhangPublished in: Journal of oncology (2023)
In conclusion, CSF cfDNA is a potential predictor of relapse and progression, which complements the monitoring value of CSF IL-10 in newly diagnosed PCNSL patients.